Kinnate Biopharma
(NASDAQ:KNTE)
$5.98
-0.46[-7.14%]
At close: Dec 9(Delayed 15-Minutes)
Get Real Time Here
$5.98
After Hours: 4:40PM EDT
Day Range5.980 - 6.59052 Wk Range5.750 - 20.070Open / Close6.380 / 5.980Float / Outstanding18.331M / 44.165M
Vol / Avg.90.654K / 188.603KMkt Cap264.105MP/E-50d Avg. Price8.930
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.331MEPS-2.520

Kinnate Biopharma Stock (NASDAQ:KNTE), Quotes and News Summary

Kinnate Biopharma Stock (NASDAQ: KNTE) stock price, news, charts, stock research, profile.

Loading...
Day Range5.980 - 6.59052 Wk Range5.750 - 20.070Open / Close6.380 / 5.980Float / Outstanding18.331M / 44.165M
Vol / Avg.90.654K / 188.603KMkt Cap264.105MP/E-50d Avg. Price8.930
Div / Yield (Forward)- / -%Payout Ratio-Total Float18.331MEPS-2.520
PRNewswire - Aug 22, 2022, 6:30AM
Seeking Alpha - Nov 17, 2022, 10:21AM
Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The company's product candidate is KIN-2787, which is a Rapidly Accelerated Fibrosarcoma (RAF) inhibitor it is developing for the treatment of patients with lung cancer, melanoma and other solid tumors. Its KIN003 program is evaluating Fibroblast Growth Factor Receptors (FGFR) inhibitor candidates for the treatment of patients with intrahepatic cholangiocarcinoma (ICC), a cancer of the bile ducts in the liver, and urothelial carcinoma (UC), a cancer of the bladder lining.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.610-0.700 -0.0900
REV0
Q2 2022Est.ActualSurprise
EPS-0.620
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Kinnate Biopharma (KNTE) stock?

A

You can purchase shares of Kinnate Biopharma (NASDAQ: KNTE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kinnate Biopharma's (KNTE) competitors?

A

There are no as such competitors for Kinnate Biopharma.

Q

What is the target price for Kinnate Biopharma (KNTE) stock?

A

The latest price target for Kinnate Biopharma (NASDAQ: KNTE) was reported by Stifel on Thursday, November 17, 2022. The analyst firm set a price target for 11.00 expecting KNTE to rise to within 12 months (a possible 83.95% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kinnate Biopharma (KNTE)?

A

The stock price for Kinnate Biopharma (NASDAQ: KNTE) is $5.98 last updated Today at December 9, 2022, 9:00 PM UTC.

Q

Does Kinnate Biopharma (KNTE) pay a dividend?

A

There are no upcoming dividends for Kinnate Biopharma.

Q

When is Kinnate Biopharma (NASDAQ:KNTE) reporting earnings?

A

Kinnate Biopharma’s Q3 earnings are confirmed for Thursday, November 10, 2022.

Q

Is Kinnate Biopharma (KNTE) going to split?

A

There is no upcoming split for Kinnate Biopharma.

Q

What sector and industry does Kinnate Biopharma (KNTE) operate in?

A

Kinnate Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.